These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9443488)

  • 1. Frontal lobe volume in patients with Huntington's disease.
    Aylward EH; Anderson NB; Bylsma FW; Wagster MV; Barta PE; Sherr M; Feeney J; Davis A; Rosenblatt A; Pearlson GD; Ross CA
    Neurology; 1998 Jan; 50(1):252-8. PubMed ID: 9443488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
    Rosas HD; Tuch DS; Hevelone ND; Zaleta AK; Vangel M; Hersch SM; Salat DH
    Mov Disord; 2006 Sep; 21(9):1317-25. PubMed ID: 16755582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research.
    Bartzokis G; Beckson M; Lu PH; Edwards N; Rapoport R; Wiseman E; Bridge P
    Psychiatry Res; 2000 Apr; 98(2):93-102. PubMed ID: 10762735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study.
    Tsuruya K; Yoshida H; Haruyama N; Fujisaki K; Hirakata H; Kitazono T
    PLoS One; 2015; 10(12):e0143706. PubMed ID: 26632813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Executive dysfunction in early stages of Huntington's disease is associated with striatal and insular atrophy: a neuropsychological and voxel-based morphometric study.
    Peinemann A; Schuller S; Pohl C; Jahn T; Weindl A; Kassubek J
    J Neurol Sci; 2005 Dec; 239(1):11-9. PubMed ID: 16185716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
    Ciarmiello A; Cannella M; Lastoria S; Simonelli M; Frati L; Rubinsztein DC; Squitieri F
    J Nucl Med; 2006 Feb; 47(2):215-22. PubMed ID: 16455626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal change in basal ganglia volume in patients with Huntington's disease.
    Aylward EH; Li Q; Stine OC; Ranen N; Sherr M; Barta PE; Bylsma FW; Pearlson GD; Ross CA
    Neurology; 1997 Feb; 48(2):394-9. PubMed ID: 9040728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cortical and frontal atrophy are associated with cognitive impairment in age-related confluent white-matter lesion.
    Mok V; Wong KK; Xiong Y; Wong A; Schmidt R; Chu W; Hu X; Leung EY; Chen S; Chen Y; Tang WK; Chen X; Ho CL; Wong KS; Wong ST
    J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):52-7. PubMed ID: 20826875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study.
    Starkstein SE; Brandt J; Bylsma F; Peyser C; Folstein M; Folstein SE
    Neuroradiology; 1992; 34(6):487-9. PubMed ID: 1436456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter lesions impair frontal lobe function regardless of their location.
    Tullberg M; Fletcher E; DeCarli C; Mungas D; Reed BR; Harvey DJ; Weiner MW; Chui HC; Jagust WJ
    Neurology; 2004 Jul; 63(2):246-53. PubMed ID: 15277616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional atrophy associated with cognitive and motor function in prodromal Huntington disease.
    Aylward EH; Harrington DL; Mills JA; Nopoulos PC; Ross CA; Long JD; Liu D; Westervelt HK; Paulsen JS;
    J Huntingtons Dis; 2013; 2(4):477-89. PubMed ID: 25062732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults.
    DeCarli C; Murphy DG; Tranh M; Grady CL; Haxby JV; Gillette JA; Salerno JA; Gonzales-Aviles A; Horwitz B; Rapoport SI
    Neurology; 1995 Nov; 45(11):2077-84. PubMed ID: 7501162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy.
    Scahill RI; Hobbs NZ; Say MJ; Bechtel N; Henley SM; Hyare H; Langbehn DR; Jones R; Leavitt BR; Roos RA; Durr A; Johnson H; Lehéricy S; Craufurd D; Kennard C; Hicks SL; Stout JC; Reilmann R; Tabrizi SJ;
    Hum Brain Mapp; 2013 Mar; 34(3):519-29. PubMed ID: 22102212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease.
    Petrou M; Davatzikos C; Hsieh M; Foerster BR; Albin RL; Kotagal V; Müller ML; Koeppe RA; Herman WH; Frey KA; Bohnen NI
    Acad Radiol; 2016 May; 23(5):577-81. PubMed ID: 26874576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis.
    Kassubek J; Juengling FD; Ecker D; Landwehrmeyer GB
    Cereb Cortex; 2005 Jun; 15(6):846-53. PubMed ID: 15459079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voluntary saccade inhibition deficits correlate with extended white-matter cortico-basal atrophy in Huntington's disease.
    Vaca-Palomares I; Coe BC; Brien DC; Campos-Romo A; Munoz DP; Fernandez-Ruiz J
    Neuroimage Clin; 2017; 15():502-512. PubMed ID: 28649493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease.
    Fennema-Notestine C; Archibald SL; Jacobson MW; Corey-Bloom J; Paulsen JS; Peavy GM; Gamst AC; Hamilton JM; Salmon DP; Jernigan TL
    Neurology; 2004 Sep; 63(6):989-95. PubMed ID: 15452288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.